EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

MCAM is Expressed in a Subset of Advanced Cutaneous Melanomas

Jacqueline E Mann iD, Adebowale Adeniran iD, Oscar Perales, Lucia Jilaveanu, Dijana Djureinovic iD, Daryl E Klein iD, Bernadette Marquez-Nostra iD, Harriet M Kluger iD

Cancer Medicine · 2026-11 · 15 (11)

DOI: 10.1002/cam4.72494 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 10.11.2026. Verfasst von Jacqueline E Mann und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Oncology, Yale University School of Medicine, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms, CD146 Antigen. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Melanoma Cell Adhesion Molecule (MCAM) is an attractive therapeutic target for several cutting‐edge treatment modalities currently in development. To better understand patient subsets with the potential to benefit from MCAM targeting, MCAM protein levels were evaluated in 451 primary and metastatic cutaneous melanoma specimens. Expression was observed in the tumor cells of 35% of specimens and was associated with metastasis and with survival in metastatic cutaneous melanoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaSkin NeoplasmsCD146 AntigenHumansFemaleMaleNeoplasm StagingMiddle AgedAgedCutaneous Malignant MelanomaNeoplasm MetastasisBiomarkers, TumorAdultAged, 80 and over

Stichwörter der Autor:innen

MCAM/MUC18/CD146melanomametastasistargeted therapy

Substanzen

CD146 AntigenMCAM protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Division of Medical Oncology, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Department of Pathology, Yale School of Medicine, New Haven, Connecticut, USA.
  • Yale Cancer Biology Institute, Yale University, West Haven, Connecticut, USA.
  • Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Division of Advanced Medical Imaging Research, Department of Radiology, University of Alabama at Birmingham, Birmingham, Alabama, USA.

ORCID-Profile: Jacqueline E Mann, Adebowale Adeniran, Dijana Djureinovic, Daryl E Klein, Bernadette Marquez-Nostra, Harriet M Kluger

Förderung

  • NCI NIH HHS
  • National Cancer Institute

Zitieren

APA

Mann, J. E., Adeniran, A., Perales, O., Jilaveanu, L., Djureinovic, D., Klein, D. E., Marquez-Nostra, B., & Kluger, H. M. (2026). MCAM is Expressed in a Subset of Advanced Cutaneous Melanomas. Cancer Medicine, 15(11). https://doi.org/10.1002/cam4.72494

Vancouver

Mann JE, Adeniran A, Perales O, Jilaveanu L, Djureinovic D, Klein DE, et al. MCAM is Expressed in a Subset of Advanced Cutaneous Melanomas. Cancer Medicine. 2026;15(11). doi:10.1002/cam4.72494

BibTeX
@article{Mann2026,
  author = {Mann, Jacqueline E and Adeniran, Adebowale and Perales, Oscar and Jilaveanu, Lucia and Djureinovic, Dijana and Klein, Daryl E and Marquez-Nostra, Bernadette and Kluger, Harriet M},
  title = {MCAM is Expressed in a Subset of Advanced Cutaneous Melanomas},
  journal = {Cancer Medicine},
  year = {2026},
  volume = {15},
  number = {11},
  doi = {10.1002/cam4.72494}
}
Kostenlos starten →